BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18487925)

  • 1. [Recurrent gallbladder carcinoma treated with combination chemotherapy with gemcitabine, CPT-11 and S-1--a successful case with metastatic tumors replaced by marked calcification].
    Nakadaira K; Kurosaki I; Ueki H
    Gan To Kagaku Ryoho; 2008 May; 35(5):837-9. PubMed ID: 18487925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A patient with recurrent gallbladder cancer responding to chemotherapy with CDDP/CPT-11 and gemcitabine].
    Yoneto T; Yoshikawa K; Fujii Y
    Gan To Kagaku Ryoho; 2005 Jan; 32(1):99-102. PubMed ID: 15675592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A resected case of effective treatment with S-1/gemcitabine and Paclitaxel combination chemotherapy for advanced pancreatic cancer with peritoneal and liver metastases].
    Kimura H; Fushida S; Mukawa A
    Gan To Kagaku Ryoho; 2009 Jul; 36(7):1191-4. PubMed ID: 19620816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curative resection of gallbladder cancer with liver invasion and hepatic metastasis after chemotherapy with gemcitabine plus S-1: report of a case.
    Okumura T; Nakamura J; Kai K; Ide Y; Nakamura H; Koga H; Ide T; Miyoshi A; Kitahara K; Noshiro H
    World J Surg Oncol; 2014 Nov; 12():326. PubMed ID: 25367161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Advanced gallbladder cancer that showed complete response to gemcitabine plus S-1 chemotherapy].
    Takita M; Iwasaki E; Hatogai K; Kishino R; Seki E; Izumiya M; Maeda N; Nakazawa A; Mizuki A; Handa K; Shimoyama Y; Mukai K; Higuchi H; Takaishi H; Hibi T; Tsukada N
    Nihon Shokakibyo Gakkai Zasshi; 2011 Jul; 108(7):1263-70. PubMed ID: 21737979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Non-surgical treatment for pancreatic cancer].
    Okusaka T; Ueno H; Ikeda M; Morizane C
    Nihon Shokakibyo Gakkai Zasshi; 2006 Apr; 103(4):391-7. PubMed ID: 16629457
    [No Abstract]   [Full Text] [Related]  

  • 7. [A Case of Locally Advanced Gallbladder Cancer That Developed Early Multiple Liver Metastasis after Curative Resection, and Achieved Long-TermPartial Remission Using S-1 and Gemcitabine].
    Hiraki S; Kanesada K; Harada T; Tada K; Fukuda S
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2086-2088. PubMed ID: 28133230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised phase II trial of irinotecan plus S-1 in patients with gemcitabine-refractory pancreatic cancer.
    Ioka T; Komatsu Y; Mizuno N; Tsuji A; Ohkawa S; Tanaka M; Iguchi H; Ishiguro A; Kitano M; Satoh T; Yamaguchi T; Takeda K; Kida M; Eguchi K; Ito T; Munakata M; Itoi T; Furuse J; Hamada C; Sakata Y
    Br J Cancer; 2017 Feb; 116(4):464-471. PubMed ID: 28081543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer.
    Stathopoulos GP; Syrigos K; Aravantinos G; Polyzos A; Papakotoulas P; Fountzilas G; Potamianou A; Ziras N; Boukovinas J; Varthalitis J; Androulakis N; Kotsakis A; Samonis G; Georgoulias V
    Br J Cancer; 2006 Sep; 95(5):587-92. PubMed ID: 16909140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
    Abdel-Rahman O; Elsayed Z; Elhalawani H
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irinotecan and fixed-dose-rate gemcitabine in advanced pancreatic and biliary cancer: phase I study.
    Sun W; Haller D
    Oncology (Williston Park); 2003 Sep; 17(9 Suppl 8):16-9. PubMed ID: 14569842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neoadjuvant chemotherapy with combination of S-1 and CPT-11 in advanced rectal cancer - a case report].
    Murakami H; Yamakawa M; Han I; Hatori S; Suzuki M; Iwasaki H; Takanashi Y
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1667-9. PubMed ID: 17940387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A long-term survival case of pancreatic cancer with hepatic metastasis after pancreaticoduodenectomy successfully treated by s-1 and gemcitabine combination chemotherapy].
    Hoshino H; Takeda Y; Nagano H; Nakamori S; Kobayashi S; Eguchi H; Marubashi S; Tanemura M; Kitagawa T; Umeshita K; Monden M; Doki Y; Mori M
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2419-21. PubMed ID: 20037442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of oral drugs in the standard therapy for metastatic colorectal cancer patients].
    Kato K
    Nihon Rinsho; 2011 Apr; 69 Suppl 3():454-8. PubMed ID: 22214003
    [No Abstract]   [Full Text] [Related]  

  • 15. [A long-term survivor treated with S-1 and gemcitabine for recurrence following an operation for advanced gall bladder cancer].
    Nakamoto Y; Ogata M; Yamamoto M
    Gan To Kagaku Ryoho; 2010 Oct; 37(10):1979-81. PubMed ID: 20948268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S-phase modulation by irinotecan: pilot studies in advanced solid tumors.
    Ramnath N; Khushalani N; Toth K; Litwin AM; Intengan ME; Slocum HK; Pendyala L; Smith PF; Stewart CC; Hoffman JL; Javle MM; Berdzik J; Creaven PJ; Rustum YM
    Cancer Chemother Pharmacol; 2005 Nov; 56(5):447-54. PubMed ID: 15947933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of gemcitabine and S-1 combination chemotherapy in patients with metastatic biliary tract cancer.
    Kim HS; Kim HY; Zang DY; Oh HS; Jeon JY; Cho JW; Park CK; Kim JH; Kim MJ; Ha HI; Kim JH; Han B; Song H; Kwon JH; Choi DR; Jung JY
    Cancer Chemother Pharmacol; 2015 Apr; 75(4):711-8. PubMed ID: 25630414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of combination therapy with S-1 and irinotecan in patients with advanced colorectal cancer.
    Goto A; Yamada Y; Yasui H; Kato K; Hamaguchi T; Muro K; Shimada Y; Shirao K
    Ann Oncol; 2006 Jun; 17(6):968-73. PubMed ID: 16603600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of long-term survival of unresectable-advanced gastric cancer due to chemotherapy].
    Kita K; Takahashi M; Nakano S; Akabane H; Yanagida N; Shomura H; Hanamoto T; Kuji M; Oikawa F; Miyagi H
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2281-3. PubMed ID: 20037396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002).
    Narahara H; Iishi H; Imamura H; Tsuburaya A; Chin K; Imamoto H; Esaki T; Furukawa H; Hamada C; Sakata Y
    Gastric Cancer; 2011 Mar; 14(1):72-80. PubMed ID: 21340666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.